Sleep and Blankets
SWAN
2 other identifiers
interventional
672
1 country
1
Brief Summary
Purpose The primary aim of this research project is to evaluate whether a special blanket is an effective intervention for improving sleep among young people aged 16-24 with sleep disturbances. Sleep problems are increasingly common among Danish youth, with approximately one in five reporting significant sleep difficulties in the past 14 days. This trend has been rising steadily since 2010 and is mirrored internationally. Sleep disturbances are linked to a wide range of physical and mental health problems, including stress, anxiety, and depression, as well as negative effects on academic performance and social relationships. Early intervention is crucial to prevent chronic insomnia and poor mental health outcomes in adulthood. Current treatments include specialized psychological therapies and medication. However, psychological therapies require extensive time and commitment, and medication carries risks of side effects, tolerance, and dependency, making non-pharmacological, safe, and accessible alternatives necessary. The special blanket is believed to promote relaxation through stimulation of the tactile and proprioceptive systems. Although promising in clinical and pedagogical contexts for certain populations (e.g., children with developmental disorders and adults with neurological conditions), there is limited scientific evidence regarding its efficacy and underlying mechanisms, particularly among youth with sleep disturbances. Methods and Study Design This project is a Phase 1 randomized controlled trial (RCT) assessing the effect of 4 weeks of using a special blanket on sleep problems among young people aged 16-24, as well as the impact on participants' mental and physical health. Additionally, the study investigates possible stress-related mechanisms involved in the use of the special blanket. Following the 4-week intervention, an open-label extension phase of 8 weeks (Phase 2) will explore continued use and acceptability of the blanket. Eligible participants, screened for sleep problems, will be randomly assigned to one of three groups: Group 1: receives a special blanket (Blanket A) for home use over 4 weeks. Group 2: receives another special blanket (Blanket B) for 4 weeks. Group 3 (observation group): no blanket provided but followed for 4 weeks to monitor changes in sleep problems. The 4-week intervention phase (Phase 1) includes baseline (T1, week 0), mid-intervention (T2, week 2), and post-intervention (T3, week 4) online assessments. Sleep disturbances, physical and mental health, and stress-related mechanisms will be measured using validated questionnaires administered through REDCap. The first 40 participants in Groups 1 and 2 will additionally provide saliva samples and wear a circadian rhythm monitor (activity watch). In Phase 2, participants in Groups 1 and 2 may continue using the blanket or revert to their usual bedding. At the end of Phase 2 (T4, week 12), follow-up questionnaires will assess sleep and user experience, including satisfaction, perceived benefits, barriers, and drawbacks of the blanket. Group 3 will then be offered a special blanket for an 8-week trial. Participants The investigators aim to recruit 672 young people aged 16-24 with sleep problems. Inclusion criteria are age 16-24 years and sleep problems measured by Insomnia Severity Index (score \>10). Exclusion criteria are any underlying somatic, psychological, or neurological condition significantly affecting sleep quality; use of medications affecting sleep; pregnancy; shift work or night work; previous use of special blankets for sleep improvement and insufficient Danish language skills (questionnaires in Danish). Significance and Relevance The investigators anticipate that the findings will contribute to the current understanding of the non-pharmacological management of sleep problems, related mental and physical health outcomes, and underlying stress-related mechanisms of special blanket interventions. The results will be relevant to health professionals working with sleep problems, but also to adolescents and younger adults with sleep problems and their parents. New clinical guidelines on sleep problems in children and adolescents recommend non-pharmacological treatments as the first choice, specifically mentioning the potential efficacy of special blankets. The proposed project will help inform further development of such guidelines and related clinical practice. If special blankets are found to be effective in reducing insomnia, they could serve as an inexpensive, easily disseminated, and administered treatment with no known side effects, with the potential to greatly reduce the personal, as well as societal costs of insomnia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedStudy Start
First participant enrolled
October 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
December 17, 2025
December 1, 2025
1.2 years
September 12, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity
Insomnia Severity Index (ISI) will be used to assess the severity of insomnia symptoms. The ISI is a brief self-report instrument consisting of seven items that evaluates the severity of sleep-onset, sleep maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeability of impairment attributed to the sleep problem, and level of distress caused by the sleep problem. This corresponds in part to the diagnostic criteria of insomnia. Zero is the minimum value and equivalent to no insomnia and 28 is the maximum value and indicates clinical insomnia in severe degree.
Baseline (T1), week 2 (T2), Week 4 (T3), week 12 (T4). To measure change across timepoints.
Secondary Outcomes (16)
The Pittsburgh Sleep Quality Index
Baseline (T1), week 2 (T2), Week 4 (T3), week 12 (T4). To measure change across timepoints.
Actigraphy-based sleep
Baseline (T1) and Week 4 (T3)
Diurnal salivary cortisol
Baseline (T1) and Week 4 (T3)
Stress
Baseline (T1), week 2 (T2), Week 4 (T3), week 12 (T4). To measure change across timepoints.
Depression
Baseline (T1), week 2 (T2), Week 4 (T3), week 12 (T4). To measure change across timepoints.
- +11 more secondary outcomes
Study Arms (3)
Group 1 (Blanket A)
EXPERIMENTALBlanket A to be used in 4 weeks (Phase 1 - RCT) and the opportunity for additional 8 weeks (Phase 2 - open trial)
Group 2 (Blanket B)
ACTIVE COMPARATORBlanket B to be used in 4 weeks (Phase 1 - RCT) and the opportunity for additional 8 weeks (Phase 2 - open trial)
Group 3 (observational)
NO INTERVENTIONSleep with their own blanket throughout the both Phase 1 and Phase 2
Interventions
Special blanket to be used at home every night in 4 weeks (Phase 1 - RCT) and opportunity for additional 8 weeks (Phase 2 - open trial)
Different special blanket to be used at home every night in 4 weeks (Phase 1 - RCT) and opportunity for additional 8 weeks (Phase 2 - open trial)
Eligibility Criteria
You may qualify if:
- Participants must be between 16 and 24 years old
- Participants must have a score on the Insomnia Severity Index (ISI) above 10.
You may not qualify if:
- Presence of neurological disorders known to influence or be related to poor sleep including affective disorders and diagnosed medical sleep disorders (e.g., sleep apnea, narcolepsy)
- Circulatory or respiratory disease
- Pregnancy, shift or night work
- Prior use of special blanket (within the past five years)
- Insufficient Danish proficiency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- University of Aarhuscollaborator
Study Sites (1)
Department of Psychology and Behavioural Sciences, Aarhus University
Aarhus, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
September 12, 2025
First Posted
September 18, 2025
Study Start
October 15, 2025
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Will not be shared